Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer
Conditions: Esophageal Cancer; Non Small Cell Lung Cancer Intervention: Biological: Personalized mRNA Tumor Vaccine Sponsors: Stemirna Therapeutics; The First Affiliated Hospital of Zhengzhou University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Esophagus Cancer | Hospitals | Lung Cancer | Non-Small Cell Lung Cancer | Research | Study | Vaccines